Skip to content
Open access

Precision Insulin-Pump Calibration and Optimal Insulin Delivery to Improve Blood Glucose Levels

Jul 2026 · medRxiv · 0 citations
Medicine

TL;DR

A simple, automated, and individualized insulin-pump calibration system based on a series of measures taken before and a few hours after carbohydrate ingestion, which modulate the shape of pre-meal insulin dosing to explicitly reduce postprandial BG levels while minimizing the likelihood of dangerously low BG.

Abstract

The successful management of type-1 diabetes (T1D) and insulin-dependent type-2 diabetes depends on the ability to accurately calibrate bolus and basal insulin doses, and minimize the time spent with high postprandial blood glucose (BG) levels while avoiding dangerously low hypoglycemic excursions. Precise calibration of the insulin pump helps with successful disease management; however, people with T1D may still experience prolonged, potentially damaging BG levels due to postprandial highs. Insulin pumps offer large, currently underexploited degrees of freedom in insulin delivery, which can have a dramatic impact on average postprandial BG levels. Building on existing models of the glucose-insulin system, we first propose a simple, automated, and individualized insulin-pump calibration system based on a series of measures taken before and a few hours after carbohydrate ingestion. We then modulate the shape of pre-meal insulin dosing to explicitly reduce postprandial BG levels while minimizing the likelihood of dangerously low BG. Such an optimal insulin delivery time course can potentially improve postprandial BG levels and rapidly bring BG to the target level. We evaluated our methods in 20 patients over 4 days, with BG levels sampled frequently.

Read PDF

Similar papers

Review Aug 2026

Early Consideration of Automated Insulin Delivery in Type 2 Diabetes: A Critical Review.

Randomized and real-world studies demonstrate that AID systems significantly improve A1C and time in range while minimizing hypoglycemia, without increasing treatment complexity or patient burden, and position AID as a practical and effective strategy to overcome long-standing therapeutic inertia in type 2 diabetes.

Z. Tariq, Grazia Aleppo, Anders L. Carlson et al. · 0 citations
Aug 2026

Self-tuned Blood Glucose (BG) Level Adjustment in Type-I Diabetes Patient based on Adaptive Control Approach

Type-I Diabetes Mellitus (TIDM) is characterized by autoimmune destruction of pancreatic β-cells, resulting in absolute insulin deficiency and impaired glucose regulation. Maintaining normoglycemia is challenging due to the nonlinear and time-varying nature of Glucose–Insulin (GI) dynamics, meal disturbances, and p...

A. Patra, Smitta Ranjan Dutta, Anuja Nanda · 0 citations
Review Open access Oct 2026

Glycemia Regulation in Type 1 Diabetes Using Artificial Pancreas Systems: One Decade Review of Positive Control Approaches

An artificial pancreas (AP) is a biomedical device that mimics the natural glucose-regulation process carried out by a healthy pancreas. This device consists of three parts: a continuous glucose monitor (CGM), a control algorithm, and an insulin pump. These three parts work together by continuously monitoring blood glu...

L. T. Rasheed, A. Alaraji, T. Mohammadridha · 0 citations
Open access Aug 2026

Continuous Glucose Monitoring-Informed Basal Insulin Optimization System in Adults with Type 2 Diabetes: Initial Evaluation of Efficacy, Safety, and Impact on Patient-Reported Outcomes

CGM-informed basal insulin optimization with a prototype of Dexcom Smart Basal was associated with improvements in glycemic control and treatment satisfaction in adults with T2D, with a favorable safety profile, and the system may help overcome clinical inertia and support individualized insulin titration in real-world...

S. Oser, C. Crystal, K. Hames et al. · 0 citations
Preprint Oct 2026

Sliding-scale Insulin Does Not Control Steroid-induced Hyperglycemia in a Non-diabetic Patient, No Matter How You Tune It

Sliding-scale insulin is the default hospital response to high blood glucose. Its correction factor was designed for patients who make no insulin, yet it is routinely ordered for patients whose pancreas still works, including those on high-dose steroids. We treat the sliding scale as what it is, a proportional controll...

Nir Regev, G. Regev · 0 citations
Open access Sep 2026

Use of Continuous Glucose Monitoring Indicators to Guide Dose Titration of Weekly Basal Insulin Efsitora Alfa in Insulin-Naive and Basal Insulin-Experienced Adults with Type 2 Diabetes: A Retrospective Analyis.

INTRODUCTION Basal insulin dose titration has historically relied on fasting self-monitoring blood glucose (SMBG) and hypoglycemic events. This retrospective analysis of the QWINT-2 and QWINT-3 Phase 3 trials aimed to evaluate the use of continuous glucose monitoring (CGM)-derived indicators for weekly insulin efsitora...

R. Bergenstal, Michael B. Davidson, David T. Ahn et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.